Jinyong Peng Selected Research

Non-alcoholic Fatty Liver Disease

10/2021	3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing.
2/2021	Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty liver disease by regulating the YAP1/TAZ-PPARγ/PGC-1α signaling pathway.
2/2018	Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway.
2/2018	Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
1/2018	Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway.
1/2018	Protection by the Total Flavonoids from Rosa laevigata Michx Fruit against Lipopolysaccharide-Induced Liver Injury in Mice via Modulation of FXR Signaling.
11/2015	Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
1/2015	Potent effects of dioscin against obesity in mice.
12/2013	Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinyong Peng Research Topics

Disease

40	Inflammation (Inflammations) 12/2019 - 11/2013
24	Neoplasms (Cancer) 01/2019 - 06/2007
18	Reperfusion Injury 12/2021 - 11/2013
10	Body Weight (Weight, Body) 01/2019 - 05/2012
9	Non-alcoholic Fatty Liver Disease 10/2021 - 12/2013
9	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020 - 04/2015
8	Acute Kidney Injury (Acute Renal Failure) 09/2019 - 11/2012
7	Fibrosis (Cirrhosis) 10/2019 - 07/2015
6	Cardiotoxicity 09/2019 - 01/2018
6	Atherosclerosis 01/2019 - 01/2014
6	Necrosis 12/2018 - 06/2009
6	Lung Neoplasms (Lung Cancer) 09/2018 - 09/2013
6	Breast Neoplasms (Breast Cancer) 07/2017 - 01/2015
5	Carcinoma (Carcinomatosis) 01/2020 - 09/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 01/2017
4	Obesity 10/2020 - 01/2015
4	Hypoxia (Hypoxemia) 01/2019 - 10/2015
4	Stomach Neoplasms (Stomach Cancer) 03/2016 - 05/2012
3	Mitochondrial Diseases (Mitochondrial Disease) 02/2022 - 10/2012
3	Wounds and Injuries (Trauma) 01/2021 - 01/2015
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2014
3	Colitis 01/2017 - 05/2015
3	Ischemia 10/2016 - 09/2014
3	Brain Ischemia (Cerebral Ischemia) 07/2016 - 11/2013
3	Colonic Neoplasms (Colon Cancer) 06/2016 - 01/2014
3	Hepatitis 03/2013 - 07/2008
2	Prostatic Neoplasms (Prostate Cancer) 08/2021 - 10/2017
2	Liver Neoplasms (Liver Cancer) 01/2019 - 09/2018
2	Insulin Resistance 11/2018 - 02/2018
2	Osteoporosis 11/2018 - 01/2016
2	Lymphoma (Lymphomas) 07/2018 - 07/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 02/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2017 - 01/2015
2	Leukemia 01/2017 - 05/2013
2	Intrahepatic Cholestasis 01/2017 - 01/2016
2	Cholestasis 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

62	dioscinIBA 05/2022 - 05/2012
16	Pharmaceutical PreparationsIBA 10/2021 - 06/2009
14	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2010
10	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2019 - 05/2013
9	Biological ProductsIBA 01/2018 - 09/2010
8	FlavonoidsIBA 12/2019 - 11/2013
8	Interleukin-6 (Interleukin 6)IBA 03/2019 - 12/2015
6	Sirtuin 1IBA 10/2019 - 11/2014
6	HMGB1 Protein (HMG1)IBA 03/2019 - 11/2014
6	Small Interfering RNA (siRNA)IBA 01/2019 - 07/2015
6	Oleanolic AcidIBA 01/2018 - 12/2015
5	Neuroprotective AgentsIBA 05/2022 - 11/2013
5	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 05/2013
5	Messenger RNA (mRNA)IBA 03/2019 - 04/2015
5	LipopolysaccharidesIBA 12/2018 - 12/2015
5	LipidsIBA 07/2018 - 09/2013
5	SaponinsIBA 06/2015 - 09/2013
5	JBP 485IBA 09/2013 - 07/2008
4	Phosphocreatine (Neoton)IBA 02/2022 - 12/2015
4	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 02/2015
4	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018 - 04/2014
4	AntioxidantsIBA 01/2018 - 11/2013
4	Triglycerides (Triacylglycerol)IBA 02/2017 - 03/2014
4	CholesterolIBA 02/2016 - 03/2014
3	MicroRNAs (MicroRNA)IBA 09/2019 - 01/2016
3	Caspase 3 (Caspase-3)IBA 01/2019 - 12/2015
3	Alanine Transaminase (SGPT)IBA 01/2019 - 03/2014
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 03/2014
3	Biomarkers (Surrogate Marker)IBA 11/2018 - 07/2015
3	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 11/2012
3	Insulin (Novolin)FDA Link 02/2018 - 12/2014
3	2- morpholinomethyl- 3- oxoolean- 12- en- 28- oic acidIBA 01/2018 - 01/2016
3	SZC017IBA 12/2017 - 12/2015
3	CytokinesIBA 01/2017 - 09/2012
3	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2015 - 10/2012
2	Estrogen ReceptorsIBA 08/2021 - 10/2017
2	Rosmarinic AcidIBA 02/2021 - 02/2019
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2019 - 08/2014
2	FructoseIBA 10/2019 - 03/2018
2	p38 Mitogen-Activated Protein KinasesIBA 10/2019 - 02/2016
2	Sirtuin 2IBA 09/2019 - 01/2018
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 03/2019 - 06/2015
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 02/2015
2	scutellarinIBA 01/2019 - 02/2018
2	TNF Receptor-Associated Factor 3IBA 01/2019 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 07/2016
2	Metformin (Glucophage)FDA LinkGeneric 10/2018 - 07/2016
2	MicellesIBA 09/2018 - 07/2017
2	Nanoparticle Drug Delivery SystemIBA 09/2018 - 07/2017
2	tocophersolanIBA 09/2018 - 07/2017
2	NF-kappa B (NF-kB)IBA 03/2018 - 01/2018
2	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 02/2018 - 02/2017
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018 - 05/2015
2	HMGB ProteinsIBA 01/2018 - 07/2015
2	CollagenIBA 09/2017 - 12/2015
2	Agammaglobulinaemia Tyrosine KinaseIBA 07/2017 - 01/2017
2	spebrutinibIBA 07/2017 - 01/2017
2	Nonesterified Fatty Acids (NEFA)IBA 02/2017 - 12/2014
2	Sulfonic AcidsIBA 01/2017 - 05/2015
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2017 - 07/2016
2	fruit bromelainIBA 01/2017 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2016 - 06/2009

Therapy/Procedure

11	Therapeutics 10/2021 - 09/2010
8	Drug Therapy (Chemotherapy) 01/2019 - 01/2014